| Sub-optimal neutralisation of omicron (B. 1.1. 529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months GR Medigeshi, G Batra, DR Murugesan, R Thiruvengadam, ... EBioMedicine 78, 2022 | 53 | 2022 |
| Development of a fast SARS-CoV-2 IgG ELISA, based on receptor-binding domain, and its comparative evaluation using temporally segregated samples from RT-PCR positive individuals F Mehdi, S Chattopadhyay, R Thiruvengadam, S Yadav, M Kumar, ... Frontiers in microbiology 11, 618097, 2021 | 34 | 2021 |
| Upconverting nanoparticle reporter–based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen I Martiskainen, SM Talha, K Vuorenpää, T Salminen, E Juntunen, ... Analytical and Bioanalytical Chemistry 413, 967-978, 2021 | 30 | 2021 |
| Comparative evaluation of SARS-CoV-2 IgG assays in India S Chaudhuri, R Thiruvengadam, S Chattopadhyay, F Mehdi, P Kshetrapal, ... Journal of Clinical Virology 131, 104609, 2020 | 27 | 2020 |
| Longitudinal serology of SARS-CoV-2-Infected individuals in India: a prospective cohort study R Thiruvengadam, S Chattopadhyay, F Mehdi, BK Desiraju, S Chaudhuri, ... The American Journal of Tropical Medicine and Hygiene 105 (1), 66, 2021 | 24 | 2021 |
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in hospitalized patients at a tertiary referral center in North India A Ray, K Singh, S Chattopadhyay, F Mehdi, G Batra, A Gupta, A Agarwal, ... MedRxiv, 2020.08. 22.20179937, 2020 | 13 | 2020 |
| A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant N Hingankar, S Deshpande, P Das, ZA Rizvi, CK Wibmer, P Mashilo, ... PLoS pathogens 18 (4), e1010465, 2022 | 9 | 2022 |
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in admitted patients at a tertiary referral centre in North India A Ray, K Singh, F Mehdi, S Chattopadhyay, RS Jadon, N Nischal, ... medRxiv, 2022.08. 19.22278876, 2022 | 1 | 2022 |
| Long-term durable humoral immune response to heterologous antigenic exposure post six months by natural SARS-CoV-2 infection and vaccination G Batra, D Rathna Murugesan, S Chattopadhyay, F Mehdi, Ayushi, ... medRxiv, 2022.02. 23.22271381, 2022 | 1 | 2022 |
| Seroprevalence of anti-SARS-CoV-2 IgG antibody in hospitalized patients: Results of the first hospital-based serosurvey from India A Ray, K Singh, G Batra, N Wig, N Vikram, S Chattopadhyay, F Mehdi European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting G Batra, DR Murugesan, S Raghavan, S Chattopadhyay, F Mehdi, ... Indian Journal of Medical Research 157 (6), 509-518, 2023 | | 2023 |
| Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth S Deshpande, MY Ansari, J Sutar, P Das, N Hingankar, S Mukherjee, ... Microbiology Spectrum 11 (2), e04332-22, 2023 | | 2023 |
| Longitudinal serology in SARS-CoV-2 infected individuals in India-a prospective cohort study (preprint) R Thiruvengadam, S Chattopadhyay, F Mehdi, BK Desiraju, S Chaudhuri, ... | | 2021 |
| Seroprevalence of anti-SARS-CoV-2 IgG antibody in hospitalized patients in a tertiary referral center in North India (preprint) A Ray, K Singh, S Chattopadhyay, F Mehdi, G Batra, A Gupta, A Agarwal, ... | | 2020 |
